Painchek Ltd has released a press release.
PainChek receives $1.123 million R&D tax incentive refund
Earlier from Painchek
- US MedTech leader Karen Holzberger appointed CEO
- CEO Transition
- PainChek secures A$5.5m note to fund US expansion
- Landmark Sabra North America deployment targeting 20k beds
